Search
Dichlorobenzene
go.drugbank.com/drugs/DB14046ApprovedWithdrawnDichlorobenzene refers to any of, or a mixture of, three isomers consisting of benzene in which two of the hydrogen atoms are replaced by chlorine atoms: ortho-, meta-, and paradichlorobenzene. It is a constituent of the ear-wax removal ...
Categories: Cytochrome P-450 Substrates, Cytochrome P-450 CYP2E1 Substrates(S)-Warfarin
go.drugbank.com/drugs/DB14055InvestigationalWarfarin consists of a racemic mixture of two active enantiomers—R- and S- forms—each of which is cleared by different pathways. S-warfarin is 2-5 times more potent than the R-isomer in producing an anticoagulant response.
Categories: Cytochrome P-450 Substrates, Cytochrome P-450 CYP2C18 SubstratesDexverapamil
go.drugbank.com/drugs/DB14063ExperimentalCategories: P-glycoprotein inhibitors, Cytochrome P-450 SubstratesEmopamil
go.drugbank.com/drugs/DB14064ExperimentalPrevents renal injury after warm & cold ischemia.
Categories: P-glycoprotein inhibitors, Cytochrome P-450 SubstratesLomerizine
go.drugbank.com/drugs/DB14065ExperimentalLomerizine is a diphenylmethylpiperazine calcium channel blocker with relatively selective central nervous system (CNS) effects. This drug is used to prophylactically treat migraines and is also being investigated against eye-related dis...
Categories: P-glycoprotein inhibitors, Cytochrome P-450 SubstratesONT-093
go.drugbank.com/drugs/DB14069ExperimentalONT-093 is an orally bioavailable inhibitor of P-glycoprotein (P-gp). … In pre-clinical studies, ONT-093 could inhibit P-gp and reverse multidrug resistance at nM concentrations with no effect on paclitaxel pharmacokinetics.
Categories: P-glycoprotein inhibitorsMacelignan
go.drugbank.com/drugs/DB14129InvestigationalMacelignan is an NSAID with antioxidant, free radical scavenging, and neuroprotective activities.
Categories: P-glycoprotein inhibitors8-chlorotheophylline
go.drugbank.com/drugs/DB14132Experimental8-Chlorotheophylline is a stimulant drug of the xanthine chemical class, with physiological effects similar to caffeine. Its main use is in combination with Diphenhydramine as the antiemetic drug Dimenhydrinate. The stimulant properties ...
Categories: Cytochrome P-450 Substrates, Cytochrome P-450 CYP1A2 SubstratesLorvotuzumab mertansine
go.drugbank.com/drugs/DB12089InvestigationalLorvotuzumab mertansine has been used in trials studying the treatment of SCLC, Leukemia, Ovarian Cancer, Multiple Myeloma, and Merkel Cell Carcinoma, among others.
Categories: Cytochrome P-450 CYP3A Inhibitors, Cytochrome P-450 CYP3A4 InhibitorsSecoisolariciresinol
go.drugbank.com/drugs/DB12179InvestigationalSecoisolariciresinol has been used in trials studying the prevention of Breast Cancer.
Categories: P-glycoprotein inhibitors